Trials / Terminated
TerminatedNCT00282139
Aripiprazole in the Treatment of Tourette's Syndrome
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- —
Summary
This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.
Detailed description
This is an open-label, flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS (or chronic tic disorder) subjects with or without associated OC symptoms and with or without ADHD symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2006-01-25
- Last updated
- 2011-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00282139. Inclusion in this directory is not an endorsement.